查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1929449

寵物病毒快速診斷試劑盒市場（按產品類型、動物類型、技術、檢測時間、最終用戶和銷售管道），全球預測，2026-2032年

Pet Virus Rapid Diagnosis Kit Market by Product Type, Animal Type, Technology, Assay Time, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年寵物病毒快速診斷試劑盒市值為 1.6818 億美元，預計到 2026 年將成長至 1.8858 億美元，到 2032 年預計將達到 2.956 億美元，複合年成長率為 8.39%。

主要市場統計數據
基準年 2025 1.6818億美元
預計年份：2026年 1.8858億美元
預測年份：2032年 2.956億美元
複合年成長率 (%) 8.39%

動物健康管理中對快速診斷和應對的需求日益成長，使得照護現場和實驗室診斷成為獸醫、生產者和研究機構的策略重點。人們對人畜共患感染疾病風險的認知不斷提高，生物安全要求日益嚴格，以及為最大限度減少治療延誤所做的努力，共同推動了對可靠、快速的動物通用病毒檢測解決方案的需求成長。目前，診斷試劑盒市場涵蓋免疫檢測、側向層析和分子平台等多種類型，這些產品正在不斷改進，以滿足物種特異性需求、使用者人體工學以及多樣化的操作環境。

臨床醫生和檢查室管理人員要求檢測方法能夠在不影響分析完整性的前提下縮短結果週轉時間，而生產商和公共衛生機構則要求採用能夠與監測系統對接的標準化工作流程。因此，產品開發人員需要在提高靈敏度和特異性的同時，兼顧可製造性和易用性。同時，監管管道和報銷模式也在不斷發展，以適應中心實驗室之外的分散式檢查。本文透過重點闡述臨床需求、技術成熟度和營運實際情況如何影響獸醫診斷價值鏈中的產品設計、採購實務和部署策略，為後續分析提供了一個框架。

技術創新、分散式檢查和數據協作將如何重新定義動物健康領域的診斷服務和競爭優勢

動物病毒診斷生態系統正受到多種趨勢的融合影響而重塑，這些趨勢加速了創新並重新分配了價值鏈上的價值。分子化學和攜帶式設備的進步使得以往僅限於中心檢查室的檢測靈敏度能夠在現場環境中實現。同時，數位化連接和基於雲端的數據聚合正在將一次性診斷設備轉變為即時監測網路中的節點，為臨床決策和人群層面的干涉措施提供資訊。

美國近期關稅措施對獸醫診斷領域供應鏈韌性、籌資策略和採購優先事項的影響

美國近期關稅調整和貿易政策變化，為診斷試劑生產商和經銷商的供應鏈規劃、採購經濟效益和本地化策略帶來了新的考量。進口試劑、塑膠耗材和特殊組件的關稅波動導致成本增加，促使企業重新評估供應商組合、重新談判供應商契約，並探索近岸外包機會，以降低跨境成本波動帶來的風險。

高解析度細分分析揭示了產品類型、目標動物、技術、最終用戶、分銷管道、測試時間等因素如何決定採用趨勢。

細分市場觀點揭示了產品開發和商業化工作的重點方向，從而滿足多樣化的臨床和營運需求。依產品類型分類的市場結構包括：適用於批量檢測通訊協定的ELISA試劑盒、專為快速照護現場篩檢設計的橫向流動化驗試劑盒，以及提供高分析精度的PCR試劑盒，用於確證檢測。每個產品系列都針對不同的應用場景，從分散式篩檢到實驗室層級的確證檢測，這會影響採購優先順序和培訓需求。

在全球主要市場中，採用率、監管要求和分銷網路方面的區域差異會影響商業和產品策略。

區域趨勢對技術採納模式、法規要求和分銷策略有顯著影響。在美洲，臨床網路和大規模獸醫服務提供者優先考慮即時檢測的便利性和與電子健康記錄的整合，因此推動了對兼具速度和可追溯數據輸出的檢測方法的需求。該地區完善的檢查室基礎設施也支持分子確診檢測的廣泛應用，從而實現了從快速篩檢開始的循序漸進的診斷流程。

獸醫診斷生態系的競爭格局正受到產品系列多元化、合作研發和服務驅動型商業化的影響。

獸用病毒診斷領域的競爭活動以產品系列多元化、策略聯盟以及對研發和生產規模的定向投資為特徵。現有診斷公司不斷拓展其獸用產品組合，包括擴大產品線、提高與儀器平台的兼容性以及增強試劑的穩定性，以降低檢測間的差異。同時，一些專業供應商則專注於細分市場產品，例如高通量分子檢測板和用於農場的超快速就地檢驗。

圍繞產品設計、供應鏈穩健性、數位整合和客製化市場推廣模式，採取切實可行的策略行動，以推動產品普及。

產業領導者應優先考慮切實可行的措施，使產品設計、供應鏈韌性和客戶體驗與不斷變化的終端使用者期望保持一致。首先，投資於支援快速篩檢和確診分子檢測的模組化檢測平台，可以讓客戶以最小的再培訓成本採用分級診斷管道。其次，制定完善的供應商選擇計畫和區域製造夥伴關係，可以降低跨境成本波動的風險，並在需求激增時提高應對力。

我們採用嚴謹的混合方法研究途徑，結合相關人員訪談、技術審查和檢驗，得出了切實可行的結論。

本研究採用多方面方法，以確保研究結果對商業、臨床和監管領域的決策者俱有可靠性和適用性。主要研究包括對執業獸醫、診斷實驗室主任、畜牧業採購負責人和檢測開發技術專家進行結構化訪談，以收集關於性能要求、工作流程限制和採購標準的一線觀點。次要研究包括查閱同行評審文獻、監管指導文件、專利申請和製造商的技術規範，檢驗技術聲明並闡明創新軌跡。

綜合分析技術、營運韌性和以使用者為中心的設計將如何影響未來的應用和策略重點。

總而言之，動物保健領域的快速病毒診斷試劑盒正處於一個轉折點，技術進步、營運需求和不斷變化的法規相互交織，既帶來了新的機遇，也帶來了新的挑戰。速度、分析性能和易用性之間的平衡將決定哪些解決方案能夠被臨床、實驗室、研究機構和生產環境廣泛採用。受貿易政策和零件供應狀況影響的供應鏈因素，在產品規劃和商業化策略中扮演核心角色，迫使企業實現採購多元化並加強在地化能力。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：寵物病毒快速診斷試劑盒市場（依產品類型分類）

  • ELISA試劑盒
  • 橫向流動化驗盒
  • PCR試劑盒

第9章 寵物病毒快速診斷試劑盒市場（依動物類型分類）

  • 伴侶動物
    • 貓咪病毒檢測套組
    • 犬病毒檢測套組
  • 實驗動物
  • 家畜
    • 牛病毒檢測套組
    • 家禽病毒檢測套組
    • 豬病毒檢測套組

第10章：寵物病毒快速診斷試劑盒市場（依技術分類）

  • 免疫檢測
  • 分子診斷
  • 照護現場

第11章：按檢測時間分類的寵物病毒快速診斷試劑盒市場

  • 擴大
  • 迅速地
  • 標準

第12章：寵物病毒快速診斷試劑盒市場（依最終用戶分類）

  • 診所
  • 檢查室
  • 研究所
  • 獸醫診所

第13章：寵物病毒快速診斷試劑盒市場（依通路分類）

  • 直銷
  • 經銷商
  • 線上
  • 零售藥房

第14章：寵物病毒快速診斷試劑盒市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：寵物病毒快速診斷試劑盒市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國寵物病毒快速診斷試劑盒市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國寵物病毒快速診斷試劑盒市場

第17章：中國寵物病毒快速診斷試劑盒市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abaxis, Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioNote, Inc.
  • Bio-X Diagnostics
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Creative Diagnostics
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Merck & Co., Inc.
  • Neogen Corporation
  • NTBIO Diagnostics, Inc.
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Group Co., Ltd.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-0A38069517A9

The Pet Virus Rapid Diagnosis Kit Market was valued at USD 168.18 million in 2025 and is projected to grow to USD 188.58 million in 2026, with a CAGR of 8.39%, reaching USD 295.60 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 168.18 million
Estimated Year [2026] USD 188.58 million
Forecast Year [2032] USD 295.60 million
CAGR (%) 8.39%

The rapid diagnose-and-respond imperative for animal health has elevated point-of-care and laboratory diagnostics into a strategic priority for veterinarians, producers, and research institutions. Growing awareness of zoonotic risk, intensifying biosecurity mandates, and the drive to minimize treatment lag have collectively increased demand for reliable, rapid virus detection solutions tailored to animals. The landscape of diagnostic kits now spans immunoassays, lateral flow devices, and molecular platforms that are being reconfigured to address species-specific needs, user ergonomics, and varied operating environments.

Clinicians and laboratory directors are seeking tests that reduce turnaround time without compromising analytical integrity, while producers and public health authorities ask for standardized workflows that integrate with surveillance systems. As a result, product developers are balancing sensitivity and specificity improvements with manufacturability and ease of use. Meanwhile, regulatory pathways and reimbursement models are evolving to accommodate decentralized testing outside central laboratories. This introduction frames the subsequent analysis by highlighting how clinical demand, technology maturation, and operational realities are shaping product design, procurement practices, and deployment strategies across the veterinary diagnostics value chain.

How technological innovation, decentralized testing, and data connectivity are redefining diagnostics delivery and competitive advantage across animal health

The diagnostic ecosystem for animal viruses is being reshaped by converging trends that accelerate innovation and redistribute value across the supply chain. Advances in molecular chemistry and portable instrumentation are enabling assay sensitivity once confined to centralized labs to be replicated in field-friendly formats. Concurrently, digital connectivity and cloud-enabled data aggregation are transforming single-use diagnostics into nodes of real-time surveillance networks that inform clinical decisions and population-level interventions.

Operational shifts are also evident: clinics and on-farm users increasingly expect assay interfaces that require minimal training, while diagnostic laboratories prioritize throughput, automation, and multiplexing capability. Manufacturers are responding by modularizing platforms to support both rapid lateral flow screening and confirmatory molecular testing within integrated workflows. Regulatory authorities are reducing friction for emergency use and conditional approvals, accelerating commercial entry for validated technologies. Together, these transformative shifts are creating a more resilient, responsive diagnostic environment in which speed, portability, and data integration determine competitive differentiation and adoption trajectories.

Impacts of recent United States tariff policies on supply chain resilience, sourcing strategies, and procurement priorities in veterinary diagnostics

Recent tariff adjustments and trade policy developments in the United States have introduced new considerations for supply chain planning, procurement economics, and localization strategies among diagnostics manufacturers and distributors. Tariff-driven cost variances for imported reagents, plastic consumables, and specialised components have prompted organizations to reassess vendor portfolios, renegotiate supplier contracts, and explore nearshoring opportunities to reduce exposure to cross-border cost volatility.

In response, many firms have accelerated qualification of alternative suppliers, prioritized dual-sourcing for critical inputs, and increased inventory buffers for high-risk items. These adaptations aim to preserve continuity of reagent supply and maintain predictable product pricing for end users. In parallel, some manufacturers are evaluating domestic contract manufacturing partners to shorten lead times and improve control over quality assurance processes. While tariffs influence cost dynamics, their most significant impact has been to catalyze operational resilience measures that alter procurement cycles, capital allocation, and the strategic calculus for geographic expansion.

High-resolution segmentation analysis revealing how product types, animal targets, technologies, end users, channels, and assay times determine adoption dynamics

A granular segmentation perspective illuminates where product development and commercialization efforts should concentrate to meet diverse clinical and operational needs. Based on Product Type, the landscape includes ELISA kits suited to batch testing protocols, lateral flow assay kits designed for rapid, point-of-care screening, and PCR kits that deliver high analytical precision for confirmatory testing. Each product family addresses different use cases, from decentralized screening to laboratory-grade confirmation, and influences procurement preferences and training requirements.

Based on Animal Type, end users manage distinct clinical pathways across Companion Animals, Laboratory Animals, and Livestock; within companion animals, diagnostics tailored to cats and dogs must account for species-specific viral targets and clinic workflow, while livestock solutions for cattle, poultry, and swine prioritize throughput, ruggedness, and integration with herd health programs. Based on Technology, choices span Immunoassay methods that balance cost and convenience, Molecular Diagnostics that emphasize sensitivity and multiplex capability, and Point Of Care options that prioritize speed and ease of use. Based on End User, clinics, diagnostic laboratories, research institutes, and veterinary hospitals exhibit different purchasing cycles, validation requirements, and volume demands that shape product configuration and service offerings. Based on Sales Channel, direct sales, distributors, online platforms, and retail pharmacy routes each present unique commercialization pathways and margin structures. Based on Assay Time, extended, rapid, and standard assay durations determine workflow alignment, clinical utility, and user acceptance, with rapid assays increasingly favored where immediate decision-making affects treatment or containment.

Regional differentiation in adoption, regulatory expectation, and distribution that shapes commercial and product strategies across major global markets

Regional dynamics exert a strong influence on technology adoption patterns, regulatory expectations, and channel strategies. In the Americas, clinical networks and large veterinary service providers emphasize point-of-care convenience and integration with electronic health records, driving demand for assays that combine speed with traceable data outputs. The region's established laboratory infrastructure also supports wider deployment of molecular confirmatory testing, enabling tiered diagnostic workflows that begin with rapid screening.

In Europe, Middle East & Africa, heterogeneity in regulatory regimes and resource availability requires flexible commercialization approaches. High-income markets within the region prioritize standardized validation and interoperability, while emerging markets demand cost-effective, robust devices that tolerate variable supply chain conditions. Public health priorities and export controls in some jurisdictions further shape procurement timelines. In the Asia-Pacific region, growth in companion animal ownership, intensified livestock production, and rapid adoption of mobile-enabled health solutions create fertile conditions for innovative kit formats and digitally enabled services. Local manufacturing capacity and regional distribution networks play a significant role in reducing lead times and enabling tailored product offerings to meet diverse user needs across each geography.

Competitive dynamics shaped by portfolio diversification, collaborative R&D, and service-centric commercialization in the veterinary diagnostics ecosystem

Competitive activity in the veterinary virus diagnostics arena is characterized by portfolio diversification, strategic partnerships, and targeted investments in R&D and manufacturing scale. Established diagnostics companies continue to broaden their veterinary portfolios through product line extensions, instrument-platform compatibility, and reagent robustness improvements that reduce per-test variability. Simultaneously, specialized vendors focus on niche offerings such as highly multiplexed molecular panels or ultra-rapid point-of-care assays designed for on-farm deployment.

Collaborations between diagnostic developers, academic research centers, and instrument manufacturers are accelerating translation of emerging biomarkers into validated assays. Contract manufacturing organizations and reagent suppliers have also become pivotal partners, enabling faster scale-up and localized production. Commercial strategies increasingly blend direct engagement with veterinary networks and digital channel expansion, while value-added services-such as remote training, assay verification kits, and data analytics dashboards-are being used to differentiate offerings and deepen customer relationships. Together, these movements point to an increasingly sophisticated competitive environment in which technological capability, go-to-market agility, and service ecosystems determine long-term traction.

Actionable strategic measures for product architecture, supply chain robustness, digital integration, and tailored go-to-market models to drive adoption

Industry leaders should prioritize a set of actionable measures that align product design, supply chain resilience, and customer experience with evolving end-user expectations. First, investing in modular assay platforms that support both rapid screening and confirmatory molecular testing will enable customers to implement tiered diagnostic pathways without extensive retraining. Second, developing robust supplier qualification programs and regional manufacturing partnerships can reduce exposure to cross-border cost fluctuations and improve responsiveness during demand surges.

Third, embedding digital connectivity and secure data management in kit design will enhance clinical utility by enabling test result traceability, aggregation for surveillance, and seamless integration with practice management systems. Fourth, tailoring go-to-market strategies by end user segment-differentiating support for clinics, diagnostic laboratories, research institutes, and veterinary hospitals-will improve adoption and lifetime value. Fifth, investing in clear, species-specific validation materials and training resources will accelerate trust among clinicians treating companion animals and producers managing livestock. Finally, leaders should consider flexible commercial models that combine device-as-a-service, reagent subscription plans, and bundled training to lower adoption barriers and create predictable revenue streams. These measures collectively increase resilience and align commercial execution with real-world clinical needs.

Rigorous mixed-methods research approach combining stakeholder interviews, technical review, and triangulation to underpin actionable conclusions

The research drew on a multi-method approach designed to ensure the reliability and applicability of findings for decision-makers across commercial, clinical, and regulatory domains. Primary research included structured interviews with practicing veterinarians, diagnostic laboratory directors, procurement managers in livestock operations, and technical specialists in assay development to capture first-hand perspectives on performance requirements, workflow constraints, and procurement criteria. Secondary research encompassed review of peer-reviewed literature, regulatory guidance documents, patent filings, and manufacturer technical specifications to validate technological claims and contextualize innovation trajectories.

Data synthesis employed triangulation techniques that compared qualitative insights with documented specifications and regulatory frameworks to identify consistent patterns and credible divergences. Internal quality controls included source verification, cross-interview validation, and methodological transparency to document assumptions and limitations. The research also incorporated scenario mapping to explore how supply chain shocks, regulatory shifts, or rapid technology breakthroughs could alter adoption pathways. This methodology provided a robust evidentiary basis for the recommendations and insights presented, while acknowledging areas where additional primary data collection or longitudinal monitoring would strengthen confidence.

Consolidated conclusions on how technology, operational resilience, and user-centric design will determine future adoption and strategic priorities

In summary, rapid viral diagnostic kits for animal health are at an inflection point where technological progress, operational demands, and regulatory evolution converge to create new opportunities and challenges. The balance of speed, analytical performance, and ease of deployment will determine which solutions earn routine use in clinics, laboratories, research settings, and production environments. Supply chain considerations, influenced by trade policies and component availability, now play a central role in product planning and commercialization strategies, prompting companies to diversify sourcing and strengthen regional capabilities.

Going forward, success will favor organizations that combine scientifically robust assays with scalable manufacturing, strong customer support, and digitally enabled workflows. By aligning product development with the nuanced needs of companion animal care, laboratory science, and livestock management, developers and distributors can deliver diagnostics that not only improve clinical outcomes but also support broader surveillance and biosecurity objectives. The insights in this summary are intended to help decision-makers prioritize investments, structure partnerships, and design offerings that respond to the practical realities of veterinary diagnostics deployment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Virus Rapid Diagnosis Kit Market, by Product Type

  • 8.1. ELISA Kits
  • 8.2. Lateral Flow Assay Kits
  • 8.3. PCR Kits

9. Pet Virus Rapid Diagnosis Kit Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Cat Virus Kit
    • 9.1.2. Dog Virus Kit
  • 9.2. Laboratory Animals
  • 9.3. Livestock
    • 9.3.1. Cattle Virus Kit
    • 9.3.2. Poultry Virus Kit
    • 9.3.3. Swine Virus Kit

10. Pet Virus Rapid Diagnosis Kit Market, by Technology

  • 10.1. Immunoassay
  • 10.2. Molecular Diagnostics
  • 10.3. Point Of Care

11. Pet Virus Rapid Diagnosis Kit Market, by Assay Time

  • 11.1. Extended
  • 11.2. Rapid
  • 11.3. Standard

12. Pet Virus Rapid Diagnosis Kit Market, by End User

  • 12.1. Clinics
  • 12.2. Diagnostic Laboratories
  • 12.3. Research Institutes
  • 12.4. Veterinary Hospitals

13. Pet Virus Rapid Diagnosis Kit Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online
  • 13.4. Retail Pharmacy

14. Pet Virus Rapid Diagnosis Kit Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pet Virus Rapid Diagnosis Kit Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pet Virus Rapid Diagnosis Kit Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Pet Virus Rapid Diagnosis Kit Market

18. China Pet Virus Rapid Diagnosis Kit Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abaxis, Inc.
  • 19.6. Abbott Laboratories
  • 19.7. Bio-Rad Laboratories, Inc.
  • 19.8. bioMerieux SA
  • 19.9. BioNote, Inc.
  • 19.10. Bio-X Diagnostics
  • 19.11. Boehringer Ingelheim International GmbH
  • 19.12. Ceva Sante Animale S.A.
  • 19.13. Creative Diagnostics
  • 19.14. Heska Corporation
  • 19.15. IDEXX Laboratories, Inc.
  • 19.16. IDvet
  • 19.17. Merck & Co., Inc.
  • 19.18. Neogen Corporation
  • 19.19. NTBIO Diagnostics, Inc.
  • 19.20. QIAGEN N.V.
  • 19.21. Randox Laboratories Ltd.
  • 19.22. Thermo Fisher Scientific Inc.
  • 19.23. URIT Medical Electronic Group Co., Ltd.
  • 19.24. Virbac S.A.
  • 19.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 200. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 209. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)